Stanford Medicine researchers have developed a powerful new artificial intelligence model that can distinguish between male and female brains.

The award will facilitate a clinical trial testing the safety of CAR-T cells — immune cells from patients’ own bodies that have been bioengineered to destroy cancer cells — used to treat a deadly brain cancer.

New technology combines radiotherapy with real-time detection of cancer cells to target moving tumors or multiple metastases. Stanford Medicine is the first to research the technology in the clinic.

Previous large health studies didn’t collect sexual orientation and gender identity information. A Stanford Medicine study finds the All of Us Research Program a boon to LGBTQ health researchers, future health outcomes.

Stanford Medicine researchers find that using in vitro fertilization with testing embryos for inherited diseases would significantly reduce costs.

An anticipated growth in veterans seeking cancer care catalyzes talks to develop state-of-the-art collaboration between VA and Stanford Medicine.

Using surveys, cognitive tests and brain imaging, researchers have identified a type of depression that affects about a quarter of patients. The goal is to diagnose and treat the condition more precisely.

Questions about sexual orientation, gender identity and chosen names will be included in Stanford Medicine’s We Ask Because We Care initiative aimed at eliminating health disparities.

The Stanford Medicine psychiatrist was an expert in the development of psychopathologies and a beloved mentor to many.

An updated scoring system developed by Stanford Medicine researchers will more accurately prioritize patients on the liver transplant waiting list based on medical urgency.